Page results
-
The UCLH cardio-oncology service provides a centralised, high-quality, consultant-based outpatient clinical service.
-
Waldenström’s macroglobulinaemia is a rare form of lymphoma (a type of bone marrow cancer), treated at UCLH.
-
This page is for parents and carers of children with sickle cell disease. It explains what happens during a Transcranial Doppler Scan.
-
The UCLH dermatology department diagnoses and treats all forms of skin cancer including low- and high- risk basal cell carcinomas (BCC), squamous cell carcinomas (SCC) and malignant melanoma.
-
UCLH cancer services are closely located in and around University College Hospital, which is a one-minute walk from Warren Street and Euston Square tube stations. It’s a 15-minute walk from London King’s Cross St Pancras and Euston stations, and a few minutes on the Circle Line from Paddington Station.
-
UCLH's Haemostasis and thrombosis hub signposts patients to a range of services for blood disorders.
-
This page explains what you can expect during recovery from your CAR T-cell therapy.
-
The aim of this page is to give information about how we induce labours.
-
Information about total penectomy and perineal urethrostomy for patients referred to UCLH.
-
UCLH has a comprehensive lung cancer service and sees patients from across the UK.
File results
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023